ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

SURVEY: Cognitive Impairment II

Natural Bladder Control, Go Less and Live More

Vital Molecule Increases Cellular Energy and Improves Cognitive Function

Top Vitamin and Mineral Deficiencies — Are You at Risk?

How Pomegranate May Protect Against Cancer

Omega Fix for Obesity: How the Right Fats Fight Fat

Trimming the spare tire: Canola oil may cut belly fat

The Onion: Cancer Fighter and Food Preserver

Fighting Heartburn and Gerd Naturally – And Safely!

Probiotics improve cognition in Alzheimer's patients

 
Print Page
Email Article

Research suggests antibiotics provide little if any benefit for acute sinusitis

  [ 11 votes ]   [ 2 Comments ]
www.ProHealth.com • February 15, 2012


Antibiotics for sinusitis account for 1 of every 5 antibiotic prescriptions for adults in the United States. But Amoxicillin, the antibiotic commonly prescribed when a bacterial sinus infection (acute rhinosinusitis) is diagnosed, helps no more than a placebo, according to a new study published Feb 15 in JAMA.

Acute rhinosinusitis is a common disease associated with significant illness, lost time from work, and treatment costs. According to the report’s background section:

"Considering the public health threat posed by increasing antibiotic resistance, strong evidence of symptom relief is needed to justify prescribing of antibiotics for this usually self-limiting disease. Placebo-controlled clinical trials to evaluate antibiotic treatment have had conflicting results, likely due to differences in diagnostic criteria and outcome assessment."

Testing Current Treatment Guidelines

Evidence-based guidelines for this condition recommend reserving antibiotic treatment for patients with moderately severe or severe symptoms. Dr. Jane M. Garbutt and colleagues from the Washington University School of Medicine, St. Louis, conducted a study to examine the effect of amoxicillin treatment over symptomatic treatments on disease-specific quality of life in adults with clinically diagnosed acute bacterial rhinosinusitis.

The trial included 166 adults (36% male) who were randomized to receive a 10-day course of either amoxicillin (1,500 mg/d; n = 85) or placebo (n = 81) administered in 3 doses per day.

Some of the most common symptoms reported by participants at the beginning of the study included facial pain or pressure, postnasal discharge, and cough and runny nose.

All patients received a 5- to 7-day supply of symptomatic treatments for pain, fever, cough, and nasal congestion to use as needed; 92% concurrently used 1 or more symptomatic treatments (94% for amoxicillin group vs. 90% for control group).

The primary outcome for the study was an improvement in disease-specific quality of life after 3 to 4 days of treatment as assessed with the Sinonasal Outcome Test-16 (minimally important difference of 0.5 units on a 0-3 scale). Secondary outcomes included the patient's assessment of change in sinus symptoms and functional status, recurrence or relapse, and satisfaction with and adverse effects of treatment. The outcomes were assessed by a telephone interview at days 3, 7, 10, and 28.

• The researchers found that the average change in test scores was similar in both groups at day 3 (amoxicillin group, 0.59; control group, 0.54) and at day 10 (average difference between groups, 0.01), but differed at day 7, favoring amoxicillin (average difference between groups of 0.19).

"There were no statistically significant differences in reported symptom improvement at day 3 (37% for amoxicillin group vs. 34% for control group) or at day 10 (78% for amoxicillin group vs. 80% for control group). At day 7, more participants treated with amoxicillin reported symptom improvement (74% for amoxicillin group vs. 56% for control group)."

• The authors found there was also no difference by study group in terms of days missed from work or inability to perform usual activities; rates of relapse and recurrence by 28 days; additional health care use; and satisfaction with treatment.

• No serious adverse events occurred. The study groups did not differ in reporting adverse effects from the study medication.

The researchers write:

"There is now a considerable body of evidence from clinical trials conducted in the primary care setting that antibiotics provide little if any benefit for patients with clinically diagnosed acute rhinosinusitis.
Yet, antibiotic treatment for upper respiratory tract infections is often both expected by patients and prescribed by physicians."

"The National Institute for Health and Clinical Excellence guidelines in the United Kingdom, and more recent guidelines in the United States, suggest watchful waiting as an alternative approach to the management of patients for whom reassessment is possible; this approach delays and may preclude antibiotic treatment while providing symptomatic treatments and an explanation of the natural history of the disease."

Source: Based on American Medical Association press release, Feb 15, 2012




Post a Comment

Featured Products From the ProHealth Store
Mitochondria Ignite™ with NT Factor® Ultra EPA  - Fish Oil Vitamin D3 Extreme™


Article Comments Post a Comment

Amoxicillin
Posted by: mrs.rgs
Feb 15, 2012
This antibiotic does nothing for sinus infections. It has done nothing for me for years except promote yeast growth.

Step it up, docs. And patients ... do your sinus rinse every night to wash away the day. This has helped me tremendously. Also fairly regular use of guafenesin helps keep things most and clear.

Blessings to all.
Reply Reply

Where is the real investigative reporting
Posted by: QuestiontheDr.
Feb 22, 2012
Hold on, just hold on, this was stated in another article on the web


"This study was supported by the National Institute of Allergy and Infectious Diseases. One of Dr. Garbutt’s associates reported receiving royalties for the Sino-Nasal Outcome Test and reported ties to Apex Medical."

That really concerns me and I find it very irresponsible reporting if no one dove deep in regards to that statement. Is that true that on of her associates received royalties? I'd like to hear the details on that
Reply Reply
 
Natural Pain Relief Supplements

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Natural Bladder Control, Go Less and Live More Natural Bladder Control, Go Less and Live More
Secret Nutrient for Radiant Skin Secret Nutrient for Radiant Skin
Sunshine Vitamin Has D-lightful Health Benefits Sunshine Vitamin Has D-lightful Health Benefits
Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health
Three-Step Strategy to Reverse Mitochondrial Aging Three-Step Strategy to Reverse Mitochondrial Aging

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map